Leaflet DAVERIUM 20mg tablets
Indicated for: Parkinson's disease
Route of administration: oral
Substance: dihydroergocryptine (antiparkinsonian agent)
ATC: N04BC03 (Nervous system | Dopaminergic agents | Dopamine agonists)
This medicine may affect your ability to drive or use machines.
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
This medicine may cause drowsiness or reduced alertness.
Dihydroergocryptine is a medication used for the treatment of peripheral and cerebral circulatory disorders, such as Raynaud's disease, migraines, or cerebrovascular insufficiency. It belongs to the class of ergot derivatives and works by improving blood flow and reducing vasospasms.
The medication is taken orally, usually two or three times daily, according to the doctor's instructions. It is effective in alleviating symptoms and improving patients' quality of life.
Side effects may include nausea, dizziness, low blood pressure, and, in rare cases, fibrosis. Close monitoring is essential during treatment.
Consult your doctor to discuss the benefits and risks of treatment with Dihydroergocryptine. Follow the prescribed dosage and adhere to all medical recommendations.
General data about DAVERIUM 20mg
- Substance: dihydroergocryptine
- Date of latest medicines list: 01-07-2013
- Product code: W08298001
- Concentration: 20mg
- Pharmaceutical form: tablets
- Quantity: 20
- Product type: Generic medicine
- Prescription status: P-6L - Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.